PTK2 and pancreatic neoplasm: Previous studies have also shown that FAK inhibition increases immune surveillance by overcoming the fibrotic and immunosuppressive pancreatic tumor microenvironment, which renders tumors responsive to immunotherapy (Jiang et al., 2016).